|
OMIM |
Link |
Information gain |
01 |
|
RNASE3
|
[NCBI]
|
0.00368145
|
|
|
neutropenia, chronic familial
|
[NCBI]
|
0.00365289
|
|
|
MPO
|
[NCBI]
|
0.00171297
|
|
|
immune defect due to absence of thymus
|
[NCBI]
|
0.00160323
|
|
|
RA
|
[NCBI]
|
0.00125841
|
|
|
NCR
|
[NCBI]
|
0.000796046
|
|
|
TNF
|
[NCBI]
|
0.000793311
|
|
|
asthma-related traits, susceptibility to, 3
|
[NCBI]
|
0.00073147
|
|
|
eosinophilia, familial
|
[NCBI]
|
0.00073147
|
|
|
NAD
|
[NCBI]
|
0.000683563
|
|
|
neutrophilic dermatosis, acute febrile
|
[NCBI]
|
0.000645473
|
|
|
pulmonary alveolar proteinosis, acquired
|
[NCBI]
|
0.00061387
|
|
|
IGES
|
[NCBI]
|
0.000563334
|
|
|
cyclic hematopoiesis
|
[NCBI]
|
0.000525953
|
|
|
SLE
|
[NCBI]
|
0.000450786
|
|
|
scleroderma, familial progressive
|
[NCBI]
|
0.000400009
|
|
|
myeloproliferative syndrome, transient
|
[NCBI]
|
0.000360413
|
|
|
whim syndrome
|
[NCBI]
|
0.000326312
|
|
|
hemophagocytic lymphohistiocytosis, familial, 1
|
[NCBI]
|
0.000317037
|
|
|
SCIDX1
|
[NCBI]
|
0.000194076
|
|
|
glycogen storage disease ib
|
[NCBI]
|
0.000188554
|
|
|
EGF
|
[NCBI]
|
0.000185153
|
|
|
CRC
|
[NCBI]
|
0.000171956
|
|
|
ADA
|
[NCBI]
|
0.000170813
|
|
|
RNASE2
|
[NCBI]
|
0.000155287
|
|
|
CDG2C
|
[NCBI]
|
0.000153063
|
|
|
peroxidase and phospholipid deficiency in eosinophils
|
[NCBI]
|
0.000125213
|
|
|
CHS
|
[NCBI]
|
0.000118303
|
|
|
asthma, susceptibility to
|
[NCBI]
|
0.000106215
|
|
|
hla-d histocompatibility type
|
[NCBI]
|
0.000104756
|
|
|
MDD
|
[NCBI]
|
0.000104398
|
|
|
SDS
|
[NCBI]
|
0.000102026
|
|
|
cyanosis and hepatic disease
|
[NCBI]
|
0.000100578
|
|
|
granulocytopenia with immunoglobulin abnormality
|
[NCBI]
|
0.000100578
|
|
|
immunodeficiency due to defect in mapbp-interacting protein
|
[NCBI]
|
0.000100578
|
|
|
myelolymphatic insufficiency
|
[NCBI]
|
0.000100578
|
|
|
severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-negative, nk cell-negative, due to adenosine deaminase deficiency
|
[NCBI]
|
9.53092e-05
|
|
|
NGFB
|
[NCBI]
|
9.06946e-05
|
|
|
AT
|
[NCBI]
|
7.77592e-05
|
|
|
FMF
|
[NCBI]
|
7.7549e-05
|
|
|
hyperimmunoglobulin e recurrent infection syndrome, autosomal dominant
|
[NCBI]
|
7.75174e-05
|
|
|
SCN1
|
[NCBI]
|
7.75174e-05
|
|
|
severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-negative, nk cell-positive
|
[NCBI]
|
7.33208e-05
|
|
|
splenomegaly syndrome with splenic germinal center hypoplasia and reduced circulating t-helper cells
|
[NCBI]
|
7.29363e-05
|
|
|
ataxic diplegia with defective cellular immunity
|
[NCBI]
|
7.29363e-05
|
|
|
CDG2F
|
[NCBI]
|
7.29363e-05
|
|
|
EPS
|
[NCBI]
|
7.29363e-05
|
|
|
urticaria, familial localized heat
|
[NCBI]
|
7.29363e-05
|
|
|
apnea, obstructive sleep
|
[NCBI]
|
7.23271e-05
|
|
|
CHH
|
[NCBI]
|
6.90003e-05
|
|
|
VRNI
|
[NCBI]
|
6.84092e-05
|
|
|
CVID
|
[NCBI]
|
6.76666e-05
|
|
|
EPO
|
[NCBI]
|
6.61215e-05
|
|
|
CCL17
|
[NCBI]
|
6.34833e-05
|
|
|
WAS
|
[NCBI]
|
6.26641e-05
|
|
|
CIDX
|
[NCBI]
|
6.25859e-05
|
|
|
MG
|
[NCBI]
|
5.62424e-05
|
|
|
dermographism, familial
|
[NCBI]
|
5.59107e-05
|
|
|
microcephaly with chemotactic defect and transient hypogammaglobulinemia
|
[NCBI]
|
5.59107e-05
|
|
|
immunodeficiency with hyper-igm, type 3
|
[NCBI]
|
5.59107e-05
|
|
|
bare lymphocyte syndrome, type i
|
[NCBI]
|
5.59107e-05
|
|
|
FCAS
|
[NCBI]
|
5.19763e-05
|
|
|
EGFR
|
[NCBI]
|
5.19558e-05
|
|
|
gtp cyclohydrolase i deficiency
|
[NCBI]
|
5.09811e-05
|
|
|
PBC
|
[NCBI]
|
4.70797e-05
|
|
|
gamma-glutamylcysteine synthetase deficiency, hemolytic anemia due to
|
[NCBI]
|
4.70797e-05
|
|
|
ALPS
|
[NCBI]
|
4.52051e-05
|
|
|
GFAP
|
[NCBI]
|
4.46469e-05
|
|
|
thrombocytopenic purpura, autoimmune
|
[NCBI]
|
4.39983e-05
|
|
|
asthma, nasal polyps, and aspirin intolerance
|
[NCBI]
|
4.38575e-05
|
|
|
halothane hepatitis
|
[NCBI]
|
4.38575e-05
|
|
|
PRL
|
[NCBI]
|
4.29439e-05
|
|
|
KLK3
|
[NCBI]
|
4.23025e-05
|
|
|
PCNA
|
[NCBI]
|
4.02956e-05
|
|
|
OCP
|
[NCBI]
|
3.93154e-05
|
|
|
immunoosseous dysplasia, schimke type
|
[NCBI]
|
3.87399e-05
|
|
|
HES
|
[NCBI]
|
3.87399e-05
|
|
|
KITLG
|
[NCBI]
|
3.74307e-05
|
|
|
SCN3
|
[NCBI]
|
3.66419e-05
|
|
|
phosphoglycerate kinase 1 deficiency
|
[NCBI]
|
3.47677e-05
|
|
|
kawasaki disease
|
[NCBI]
|
3.47677e-05
|
|
|
myeloma, multiple
|
[NCBI]
|
3.47677e-05
|
|
|
AR
|
[NCBI]
|
3.40721e-05
|
|
|
thrombocytosis, familial x-linked
|
[NCBI]
|
3.37658e-05
|
|
|
CSF3
|
[NCBI]
|
3.34272e-05
|
|
|
thiopurine s-methyltransferase deficiency
|
[NCBI]
|
3.15376e-05
|
|
|
THC2
|
[NCBI]
|
3.15376e-05
|
|
|
PTH
|
[NCBI]
|
3.06268e-05
|
|
|
APOE
|
[NCBI]
|
3.01712e-05
|
|
|
omenn syndrome
|
[NCBI]
|
2.88279e-05
|
|
|
CJD
|
[NCBI]
|
2.8208e-05
|
|
|
IPEX
|
[NCBI]
|
2.76239e-05
|
|
|
PHA
|
[NCBI]
|
2.65035e-05
|
|
|
NPY
|
[NCBI]
|
2.57706e-05
|
|
|
mapbp-interacting protein
|
[NCBI]
|
2.55386e-05
|
|
|
thrombasthenia of glanzmann and naegeli
|
[NCBI]
|
2.49111e-05
|
|
|
JMML
|
[NCBI]
|
2.37769e-05
|
|
|
porphyria, congenital erythropoietic
|
[NCBI]
|
2.35536e-05
|
|
|
polycythemia vera
|
[NCBI]
|
2.35536e-05
|
|
|
F3
|
[NCBI]
|
2.29909e-05
|
|
|
IL5
|
[NCBI]
|
2.26031e-05
|
|
|
RETNLB
|
[NCBI]
|
2.2446e-05
|
|
|
mannosidosis, alpha b, lysosomal
|
[NCBI]
|
2.18624e-05
|
|
|
PF4
|
[NCBI]
|
2.09919e-05
|
|
|
AVP
|
[NCBI]
|
2.09452e-05
|
|
|
CSF2
|
[NCBI]
|
2.02513e-05
|
|
|
HGF
|
[NCBI]
|
1.90576e-05
|
|
|
CCL21
|
[NCBI]
|
1.90148e-05
|
|
|
DBA
|
[NCBI]
|
1.85907e-05
|
|
|
NP
|
[NCBI]
|
1.81244e-05
|
|
|
B2M
|
[NCBI]
|
1.75054e-05
|
|
|
mycobacterium tuberculosis, susceptibility to
|
[NCBI]
|
1.71433e-05
|
|
|
granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type i
|
[NCBI]
|
1.71433e-05
|
|
|
IL2
|
[NCBI]
|
1.69749e-05
|
|
|
FIP1L1
|
[NCBI]
|
1.68087e-05
|
|
|
TAP2
|
[NCBI]
|
1.68087e-05
|
|
|
TNFRSF18
|
[NCBI]
|
1.68087e-05
|
|
|
IL23A
|
[NCBI]
|
1.68087e-05
|
|
|
CCR1
|
[NCBI]
|
1.68087e-05
|
|
|
DKC
|
[NCBI]
|
1.65849e-05
|
|
|
ACHE
|
[NCBI]
|
1.63398e-05
|
|
|
LECT2
|
[NCBI]
|
1.59763e-05
|
|
|
lymphoma, non-hodgkin, familial
|
[NCBI]
|
1.57795e-05
|
|
|
LEP
|
[NCBI]
|
1.57725e-05
|
|
|
MPG
|
[NCBI]
|
1.52511e-05
|
|
|
AOAH
|
[NCBI]
|
1.52511e-05
|
|
|
TNFRSF13C
|
[NCBI]
|
1.46092e-05
|
|
|
CML
|
[NCBI]
|
1.45678e-05
|
|
|
temporal arteritis
|
[NCBI]
|
1.43428e-05
|
|
|
XLP1
|
[NCBI]
|
1.41111e-05
|
|
|
CBFB
|
[NCBI]
|
1.40336e-05
|
|
|
OAS1
|
[NCBI]
|
1.40336e-05
|
|
|
CCL27
|
[NCBI]
|
1.30365e-05
|
|
|
IL8RB
|
[NCBI]
|
1.30365e-05
|
|
|
IGSF4
|
[NCBI]
|
1.30365e-05
|
|
|
BCL2L11
|
[NCBI]
|
1.30365e-05
|
|
|
VDR
|
[NCBI]
|
1.27739e-05
|
|
|
VIP
|
[NCBI]
|
1.22088e-05
|
|
|
PLA2G7
|
[NCBI]
|
1.2194e-05
|
|
|
LBP
|
[NCBI]
|
1.19406e-05
|
|
|
THBS1
|
[NCBI]
|
1.18175e-05
|
|
|
IGER
|
[NCBI]
|
1.16945e-05
|
|
|
SELE
|
[NCBI]
|
1.14658e-05
|
|
|
AFP
|
[NCBI]
|
1.14467e-05
|
|
|
MAN2B1
|
[NCBI]
|
1.11361e-05
|
|
|
PTK2
|
[NCBI]
|
1.11265e-05
|
|
|
CD40
|
[NCBI]
|
1.08258e-05
|
|
|
TLR4
|
[NCBI]
|
1.06558e-05
|
|
|
FLT3
|
[NCBI]
|
9.99279e-06
|
|
|
IFNA1
|
[NCBI]
|
9.92266e-06
|
|
|
SELP
|
[NCBI]
|
9.74269e-06
|
|
|
FA
|
[NCBI]
|
9.72402e-06
|
|
|
LTC4S
|
[NCBI]
|
9.50436e-06
|
|
|
TLR9
|
[NCBI]
|
9.35034e-06
|
|
|
NPM1
|
[NCBI]
|
9.19447e-06
|
|
|
sickle cell anemia
|
[NCBI]
|
9.14427e-06
|
|
|
TPMT
|
[NCBI]
|
9.11774e-06
|
|
|
MMP1
|
[NCBI]
|
9.05921e-06
|
|
|
ETS1
|
[NCBI]
|
8.85076e-06
|
|
|
SPTB
|
[NCBI]
|
8.27392e-06
|
|
|
SLPI
|
[NCBI]
|
8.25497e-06
|
|
|
DPYD
|
[NCBI]
|
7.92447e-06
|
|
|
CD40LG
|
[NCBI]
|
7.92447e-06
|
|
|
IL8
|
[NCBI]
|
7.59906e-06
|
|
|
ADORA3
|
[NCBI]
|
7.44448e-06
|
|
|
HP
|
[NCBI]
|
7.44183e-06
|
|
|
RARA
|
[NCBI]
|
7.2949e-06
|
|
|
ARMD1
|
[NCBI]
|
7.14687e-06
|
|
|
IL6
|
[NCBI]
|
6.7978e-06
|
|
|
panencephalitis, subacute sclerosing
|
[NCBI]
|
6.66271e-06
|
|
|
transcobalamin ii deficiency
|
[NCBI]
|
6.61303e-06
|
|
|
EDN1
|
[NCBI]
|
6.48834e-06
|
|
|
SOCS1
|
[NCBI]
|
6.13436e-06
|
|
|
ZNF145
|
[NCBI]
|
5.91364e-06
|
|
|
GSR
|
[NCBI]
|
5.91364e-06
|
|
|
AHR
|
[NCBI]
|
5.88326e-06
|
|
|
SPP1
|
[NCBI]
|
5.82748e-06
|
|
|
TPT1
|
[NCBI]
|
5.70395e-06
|
|
|
TNFRSF6
|
[NCBI]
|
5.70395e-06
|
|
|
WAS
|
[NCBI]
|
5.50438e-06
|
|
|
MLL
|
[NCBI]
|
5.50438e-06
|
|
|
HS
|
[NCBI]
|
5.31416e-06
|
|
|
HBB
|
[NCBI]
|
5.27636e-06
|
|
|
HMGB1
|
[NCBI]
|
5.13257e-06
|
|
|
GNRH1
|
[NCBI]
|
4.9652e-06
|
|
|
KIT
|
[NCBI]
|
4.95901e-06
|
|
|
CRH
|
[NCBI]
|
4.81814e-06
|
|
|
GAPDH
|
[NCBI]
|
4.75138e-06
|
|
|
PGK1
|
[NCBI]
|
4.55664e-06
|
|
|
MMP9
|
[NCBI]
|
4.55664e-06
|
|
|
ITGB3
|
[NCBI]
|
4.4071e-06
|
|
|
BCL2
|
[NCBI]
|
4.19374e-06
|
|
|
FOXP3
|
[NCBI]
|
4.19374e-06
|
|
|
JAK3
|
[NCBI]
|
4.19374e-06
|
|
|
MBP
|
[NCBI]
|
4.13051e-06
|
|
|
SOCS3
|
[NCBI]
|
4.12537e-06
|
|
|
POMC
|
[NCBI]
|
3.98306e-06
|
|
|
CCL2
|
[NCBI]
|
3.92794e-06
|
|
|
TFF3
|
[NCBI]
|
3.92794e-06
|
|
|
THPO
|
[NCBI]
|
3.92794e-06
|
|
|
TLR2
|
[NCBI]
|
3.8859e-06
|
|
|
TTR
|
[NCBI]
|
3.8815e-06
|
|
|
IL3
|
[NCBI]
|
3.62243e-06
|
|
|
CGD
|
[NCBI]
|
3.47799e-06
|
|
|
WRN
|
[NCBI]
|
3.35712e-06
|
|
|
CCL22
|
[NCBI]
|
3.34307e-06
|
|
|
XDH
|
[NCBI]
|
3.29874e-06
|
|
|
PTHLH
|
[NCBI]
|
3.166e-06
|
|
|
ZFP36
|
[NCBI]
|
2.99e-06
|
|
|
DHFR
|
[NCBI]
|
2.86504e-06
|
|
|
LAT
|
[NCBI]
|
2.85073e-06
|
|
|
BTK
|
[NCBI]
|
2.80578e-06
|
|
|
ichthyosis, x-linked
|
[NCBI]
|
2.76155e-06
|
|
|
PLAUR
|
[NCBI]
|
1.87947e-06
|
|
|
SOD2
|
[NCBI]
|
1.84541e-06
|
|
|
COL1A1
|
[NCBI]
|
1.81907e-06
|
|
|
VEGF
|
[NCBI]
|
1.80746e-06
|
|
|
RP
|
[NCBI]
|
1.79867e-06
|
|
|
ALB
|
[NCBI]
|
1.7255e-06
|
|
|
CFH
|
[NCBI]
|
1.70329e-06
|
|
|
TF
|
[NCBI]
|
1.61143e-06
|
|
|
CYP1A1
|
[NCBI]
|
1.24461e-06
|
|
|
AGER
|
[NCBI]
|
1.06998e-06
|
|
|
ABCB1
|
[NCBI]
|
1.01309e-06
|
|
|
TNFSF6
|
[NCBI]
|
9.52293e-07
|
|
|
FGF7
|
[NCBI]
|
9.17046e-07
|
|
|
ABP1
|
[NCBI]
|
7.46492e-07
|
|
|
MB
|
[NCBI]
|
6.55127e-07
|
|
|
CF
|
[NCBI]
|
4.48068e-07
|
|
|
PCD
|
[NCBI]
|
4.35939e-07
|
|
|
EPOR
|
[NCBI]
|
3.6605e-07
|
|
|
TG
|
[NCBI]
|
3.59234e-07
|
|
|
ALK
|
[NCBI]
|
3.04965e-07
|
|
|
TYMS
|
[NCBI]
|
2.42631e-07
|
|
|
OSM
|
[NCBI]
|
1.75895e-07
|
|
|
PLG
|
[NCBI]
|
1.34114e-07
|
|
|
CAT
|
[NCBI]
|
7.87534e-08
|
|
|
LDLR
|
[NCBI]
|
7.47018e-08
|
|
|
BCR
|
[NCBI]
|
7.38953e-08
|
|
|
G6PD
|
[NCBI]
|
6.39074e-08
|
|
|
APRT
|
[NCBI]
|
6.02882e-08
|
|
|
SERPINA6
|
[NCBI]
|
3.27596e-08
|
|
|
HBA1
|
[NCBI]
|
9.90547e-09
|
|
|
CEACAM5
|
[NCBI]
|
8.14327e-09
|
|
|
ACP5
|
[NCBI]
|
4.4727e-09
|
|
|
TFPI
|
[NCBI]
|
2.96957e-09
|
|